- Home
- CMU vs APLT Comparison
CMU vs APLT Comparison
Compare CMU & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMU
- APLT
- Stock Information
- Founded
- CMU 1987
- APLT 2016
- Country
- CMU United States
- APLT United States
- Employees
- CMU N/A
- APLT N/A
- Industry
- CMU Investment Managers
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- CMU Finance
- APLT Health Care
- Exchange
- CMU Nasdaq
- APLT Nasdaq
- Market Cap
- CMU 90.7M
- APLT 80.3M
- IPO Year
- CMU N/A
- APLT 2019
- Fundamental
- Price
- CMU $3.53
- APLT $0.50
- Analyst Decision
- CMU
- APLT Buy
- Analyst Count
- CMU 0
- APLT 7
- Target Price
- CMU N/A
- APLT $6.10
- AVG Volume (30 Days)
- CMU 82.4K
- APLT 2.6M
- Earning Date
- CMU 01-01-0001
- APLT 05-08-2025
- Dividend Yield
- CMU 4.08%
- APLT N/A
- EPS Growth
- CMU N/A
- APLT N/A
- EPS
- CMU 0.07
- APLT N/A
- Revenue
- CMU N/A
- APLT N/A
- Revenue This Year
- CMU N/A
- APLT N/A
- Revenue Next Year
- CMU N/A
- APLT $2,426.33
- P/E Ratio
- CMU $47.57
- APLT N/A
- Revenue Growth
- CMU N/A
- APLT N/A
- 52 Week Low
- CMU $2.78
- APLT $0.43
- 52 Week High
- CMU $3.38
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- CMU 40.75
- APLT 38.29
- Support Level
- CMU $3.54
- APLT $0.49
- Resistance Level
- CMU $3.63
- APLT $0.61
- Average True Range (ATR)
- CMU 0.03
- APLT 0.06
- MACD
- CMU -0.01
- APLT 0.03
- Stochastic Oscillator
- CMU 9.09
- APLT 37.68
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.